Association of the Healthcare Effectiveness Data and Information Set (HEDIS) Follow-Up Care Measures and Medication Adherence Among Medicaid Insured Children with ADHD

J Atten Disord. 2022 Feb;26(3):370-376. doi: 10.1177/1087054720986929. Epub 2021 Jan 12.

Abstract

Objectives: To assess the association of HEDIS C&M phase follow-up measure with ADHD medication adherence.

Methods: A retrospective study was conducted using Medicaid data (2014-2016) of children initiated with ADHD medication. Patients were categorized as meeting the C&M follow-up measure or not according to the HEDIS specifications. Medication adherence was measured using both Proportion of Days Covered (PDC) & Group-Based Trajectory Modeling (GBTM). The association of medication adherence with HEDIS measure was assessed using Chi-square test.

Results: Nearly all (97%) children with PDC≥0.7 and 72% of patients following the late decliner adherence trajectory met the HEDIS C&M follow-up criteria. In contrast, none of the children with PDC<0.7 and only two following rapid and slow decliner trajectories met the criteria.

Conclusion: ADHD medication adherence, regardless of how it was measured, clearly differentiated children with and without C&M phase follow-up, which essentially questions the implication of HEDIS C&M phase follow-up care measure.

Keywords: ADHD; Group-Based Trajectory Modeling (GBTM); Healthcare Effectiveness Data and Information Set (HEDIS); adherence trajectory; continuous & maintenance follow-up rate; initiation follow-up rate.

MeSH terms

  • Aftercare
  • Attention Deficit Disorder with Hyperactivity* / drug therapy
  • Child
  • Humans
  • Medicaid*
  • Medication Adherence
  • Retrospective Studies
  • United States